TrialJournal of bone and mineral metabolism2022

Efficacy and safety of romosozumab among Japanese postmenopausal women with osteoporosis and mild-to-moderate chronic kidney disease.

Akimitsu Miyauchi et al.PubMed ↗Publisher ↗

No numbers read from the abstract.